In vitro prolonged gastric residence and sustained release of atenolol using novel clay polymer nanocomposite

Applied Clay Science

Volumn 114, Issue , 2015, Pages 412-421

  Lal, Seema ^a   Datta, Monika ^a  

^a UNIVERSITY OF DELHI   (India)

Author keywords

Anti hypertension drug; Atenolol; Clay polymer nanocomposites; Montmorillonite PLGA nanocomposites; Oral drug delivery; Sustained release drug delivery

Indexed keywords

AIRSHIPS; BIOCHEMISTRY; CLAY MINERALS; COPOLYMERS; DRUG DELIVERY; DRUG PRODUCTS; EMULSIFICATION; PARTICLE SIZE; POLYMERS; RESEARCH AIRCRAFT;

ANTI-HYPERTENSION DRUGS; ATENOLOL; ORAL DRUG DELIVERY; POLYMER NANOCOMPOSITE; SUSTAINED RELEASE;

NANOCOMPOSITES;

ABSORPTION; BIOAVAILABILITY; DIGESTIVE SYSTEM; DRUG; MONTMORILLONITE; POLYMER;

EID: 84934312170     PISSN: 01691317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clay.2015.06.017     Document Type: Article

References (79)

1. Abend S., Lagaly G. Sol-gel transitions of sodium montmorillonite dispersions. Appl. Clay Sci. 2000, 16:201-227.
2. Adams M.L., Lavasanifar A., Kwon G.S. Amphiphilic block copolymers for drug delivery. J. Pharm. Sci. 2003, 92:343-1355.
3. Aguzzi C., Cerezo P., Viseras C., Caramella C. Use of clays as drug delivery systems: possibilities and limitations. Appl. Clay Sci. 2007, 36:22-36.
4. Artzner F., Geiger S., Olivier A., Allais C., Finet S., Agnely F. Interactions between poloxamers in aqueous solutions: micellization and gelation studied by differential scanning calorimetry, small angle X-ray scattering, and rheology. Langmuir 2007, 23:5085-5092.
5. Baek M., Lee J.A. Soo-Jin Choi. Mol. Cell. Toxicol. 2012, 8:95-101.
6. Barhate S.D., Patel K.M., Lokhande G.S. Der Pharm. Lett. 2011, 3(2):34-38.
7. Barrett A.M., Carter J., Fitzgerald J.D., Hull R., Count D. A new type of cardioselective adrenoceptive blocking drug. Braz. J. Pharmacol. 1973, 48:340-342.
8. Bergaya F., Theng B.K.G., Lagaly G. First Edition Handbook of Clay Science 2006, Elsevier.
9. Bhosale U.V., Devi V.K., Choudhar S. Development and in vitro-in vivo evaluation of oral drug delivery system of acyclovir loaded PLGA nanoparticles. Int. J. Drug. Deliv. 2013, 5(3):331-343.
10. BhusariVidhya K., Dhaneshwar Sunil R. Validated HPLC method for simultaneous quantitation of amlodipine besylate, atenolol, and aspirin in bulk drug and formulation. J. Pharm. Biomed. Sci. 2012, 17(09):1-6.
11. Calabresea I., Cavallaro G., Scialabba C., Licciardi M., Merli M., Sciascia L., Liria M., Liveri M. Montmorillonite nanodevices for the colon metronidazole delivery. Int. J. Pharm. 2013, 457:224-236.
12. Chaturvedi K., Umadevi S., Vaghani S. Floating matrix dosage form for propranolol hydrochloride based on gas formation technique: development and in vitro evaluation. Sci. Pharm. 2010, 78:927-939.
13. Chen Y., Zhou A., Liu B., Liang J. Tramadol hydrochloride/montmorillonite composite: preparation and controlled drug release. Appl. Clay Sci. 2010, 49:108-112.
14. Das P.R., Nanda R.M., Behara A., Nayak P.L. Gelatin blended with nanoparticle cloisite30B (Mt) for control drug delivery of anticancer drug paclitaxel. Int. Res. J. Biochem. Bioinforma. 2011, 1:35-42.
15. Depan D., Kumar A.P., Singh R.P. Cell proliferation and controlled drug release studies of nanohybrids based on chitosan-g-lactic acid and montmorillonite. Acta Biomater. 2009, 5:100.
16. Dey S., Dutta S., Mazumder B. Formulation and evaluation of floating matrix tablet of atenolol for gastro-retentive drug delivery, Int. J. Pharm. Pharm. Sci. 2012, 4(3):433-437.
17. Dey S., Mazumder B., Sankha Chattopadhyay S., Das M.K., Sinha S., Ganguly S., Dee K., Mishra M. Polymers derived from Xanthomonas campesteris and Cyamopsis tetragonolobus use as retardant materials for the formulation of sustained release floating matrix tablet of atenolol. Int. J. Biol. Macromol. 2014, 65:346-356.
18. Dong Y., Feng S.S. Poly (D, L-lactide-co-glycolide)/montmorillonite nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005, 26:6068-6076.
19. Feng S.S., Mei L., Anitha P., Gan C.W., Zhou W. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of docetaxel. Biomaterials 2009, 30:3297-3306.
20. Frishman W.H. Drug therapy: Atenolol and Timolol, two new systemic β-adrenoceptor antagonists. N. Engl. J. Med. 1982, 306:1456-1462.
21. Fudala A.A., Pálinkó I., Kiricsi I. Preparation and characterization of hybrid organic-inorganic composite materials using the amphoteric property of amino acids: amino acid intercalated layered double hydroxide and montmorillonite. Inorg. Chem. 1999, 38:4653-4658.
22. Jain R.A. The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices. Biomaterials 2000, 21:2475-2490.
23. Jain S., Datta M. Montmorillonite-PLGA nanocomposites as an oral extended drug delivery vehicle for venlafaxine hydrochloride. Appl. Clay Sci. 2014, 99(C):42-47.
24. Jain S., Datta M. Naturally occurring clay, montmorillonite, as a drug delivery vehicle for in vitro extended release of venlafaxine hydrochloride. Bull. Am. Meteorol. Soc. 2014, 3(7):672-681.
25. Janek M., Lagaly G. Proton saturation and rheological properties of smectite dispersions. Appl. Clay Sci. 2001, 19:121-130.
26. Junping Z., Hongyan W., Hong Z., Lifei X., Kangde Y. Intercalation of amido cationic drug with montmorillonite. Journal of Wuhan University of Technology-Mater. Sci. Ed. 2006, 22:250-252.
27. Kabanov A.V., Batrakova E.V., Alakhov V.Y. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J. Control. Release 2002, 82:189-212.
28. Kaur M., Datta M. Synthesis and characterization of biodegradable clay-polymer nanocomposites for oral sustained release of anti-inflammatory drug. Eur. Chem. Bull. 2013, 2(9):670-678.
29. Kaur M., Datta M. In vitro release of sodium diclofenac from poloxamer 188 modified montmorillonite as an oral drug delivery vehicle. Int. J. Pharm. Sci. 2014 a, 6(5).
30. Kaur M., Datta M. Diclofenac sodium adsorption onto montmorillonite: adsorption equilibrium studies and drug release kinetics. Adsorpt. Sci. Technol. 2014 b, 32(5).
31. Kim J., Shin S.C. Controlled release of atenolol from the ethylene-vinyl acetate matrix. Int. J. Pharm. 2004, 273:23-27.
32. Kollár T., Pálinkó I., Kónya Z., Kiricsi I. Intercalating amino acid guests into montmorillonite host. J. Mol. Struct. 2003, 651:335-340.
33. Kulkarni A., Bhatia M. Development and evaluation of regioselective bilayer floating tablets of Atenolol and Lovastatin for biphasic release profile. Iran J. Pharm. Res. 2009, 8(1):15-25.
34. Kumar P., Shuklab S., Ganurea A.L., Subudhia B.B. Development and validation of a novel isocratic RP-HPLC method for simultaneous determination of atenolol and aspirin in fixed dose combinations. Der Pharma. Chem. 2011, 3(2):13-21.
35. Kumar S., Das M., Gupta K.S., Kumar R., Chongdar A., Ghosh L.K. Design, development, optimization and evaluation of gastro-retentive floating tablets of atenolol. Der Pharm. Lett. 2013, 5(3):436-456.
36. Lakshmi M.S., Sriranjani M., Bakrudeen H.B., Kannan A.S., Mandal A.B., Reddy B.S.R. Appl. Clay Sci. 2010, 48:589-593.
37. Lambert J.F., Bergaya F. Smectites-polymer nanocomposites (Chapter 13.1). Developments of Clay Science 2013, 5A. Elsevier. Bergaya, Lagaly (Eds.).
38. Lee Y.H., Kuo T.F., Chen B.Y., Feng Y.K., Wen Y.R., Lin W.C., Lin F.H. Toxicity assessment of montmorillonite as a drug carrier for pharmaceutical applications: yeast and rats model. Biomed. Eng. Appl. Basis Commun. 2005, 17:72-78.
39. Lin F.H., Lee Y.H., Jian C.H., Wong J.M., Shieh M.J., Wang C.Y. A study of purified montmorillonite intercalated with 5-fluorouracil as drug carrier. Biomaterials 2002, 23:1981-1987.
40. Liu J., Boo W.J., Clearfield A., Sue H.J. Intercalation and exfoliation: a review on morphology of polymer nanocomposites reinforced by inorganic layer structures materials and manufacturing processes 2006, 20:143-151.
41. Majid P.A., Vander Vijgh W.J.F., De Feijter P.J., Wardeh R., Vander Wall E.E., Ross J.P. Eur. J. Cardiol. 1979, 9:419-435.
42. Manivannan R., Chakole V. Formulation and development of extended release floating tablet of atenolol. Int. J. Recent Adv. Pharm. Res. 2011, 3:25-30.
43. Mathew A., Fukuda T., Nagaoka Y., Hasumura T., Morimoto H. Curcumin loaded-PLGA nanoparticles conjugated with Tet-1 peptide for potential use in Alzheimer's disease. PLoS One 2012, 7(3):e32616. 10.1371/journal.pone.0032616.
44. Miechel L.T.Z., Gerard H.M.E., Dirk W.G., Jan F.J. In vitro degradation of nanoparticles prepared from polymers based on DL-lactide, glycolide and poly(ethylene oxide). J. Control. Release 2004, 100:347-356.
45. Mirakabad F.S.T., Koshki K.N., Akbarzadeh A., Yamchi M.R., Milani M., Zarghami N., Zeighamian V., Rahimzadeh A., Alimohammadi S., Hanifehpour Y., Joo S.W. PLGA-based nanoparticles as cancer drug delivery systems. Asian Pac. J. Cancer Prev. 2014, 15(2):517-535.
46. Olad Ali Advances in Diverse Industrial Applications of Nanocomposites 2011, 113-138. Intech, India, (Chapter 7). 1st ed.
47. Park P.P., Jonnalagadda S. Predictors of glass transition in the biodegradable polylactide and poly-lactide-co-glycolide polymers. J. Appl. Polym. Sci. 2006, 100:1983-1987.
48. Paul D.R., Robeson L.M. Polymer nanotechnology: nanocomposites. Polymer 2008, 49:3187-3204.
49. Penner D., Lagaly G. Influence of anions on the rheological properties of clay mineral dispersions. Appl. Clay Sci. 2001, 19:131-142.
50. Pereira R.N., Valente B.R., Cruz A.P., Foppa T., Murakami F.S., Silva M.A.S. Thermoanalytical study of atenolol and commercial tablets. Lat. Am. J. Pharm. 2007, 26(3):382-386.
51. Perez-Marcos B., Iglesias R., Gomez-Amoza J.L. Mechanical and drug release properties of atenolol-carbopol hydrophilic matrix tablets. J. Control. Release 1991, 17:267-276.
52. Raghvendra, Saraswathi R. Nano-clays and drug delivery system: an overview. Int. J. Pharm. World Res. 2012, 3(3):1-16.
53. Ramos-Tejeda M.M., Ontiveros A., Plaza R.C., Delgado A.V., Duran J.D.G. A rheological approach to the stability of humic acid/clay colloidal suspensions. Rheol. Acta 2003, 42:148-157.
54. Raut N.S., Deshmukh R.P., Umekar M.J., Kotagale N.R. Zinc cross-linked hydroxamated alginates for pulsed drug release. Int J Pharm Investig. 2013, 3(4):194-202.
55. Rodrigues L.A.S., Figueiras A., Veiga F., Freitas R.M., Nunes L.C.C., Filho E.C.S., Leite C.M.S. The systems containing clays and clay minerals from modified drug release: a review. Colloids Surf. B: Biointerfaces 2013, 103:642-651.
56. Rouge N., Allemann E., Gex-Fabry M. Comparative pharmacokinetic study of a floating multiple-unit capsule, a high-density multiple-unit capsule and an immediate-release tablet containing 25mg atenolol. Pharm. Acta Helv. 1998, 73:81-87.
57. Sabarikumar K., Ilavarasan P., Shaik S.M. Formulation and evaluation of nanoparticles containing atenolol by ionic gelation technique. Int. J. Res. Pharm. Nano Sci. 2012, 1(1):11-18.
58. Sastry S.V., Reddy I.K., Khan M.A. Atenolol gastrointestinal therapeutic system: optimization of formulation variables using response surface methodology. J. Control. Release 1997, 45:121-130.
59. Schmolka I.R. A review of block polymer surfactants. J. Am. Oil Chem. Soc. 1977, 54:110-116.
60. Seema, Datta M. In vitro sustained delivery of atenolol, an antihypertensive drug using naturally occurring clay mineral montmorillonite as a carrier. Eur. Chem. Bull. 2013, 2(11):942-951.
61. Seema, Datta M. Clay-polymer nanocomposites as a novel drug carrier: synthesis, characterization and controlled release study of propranolol hydrochloride. Appl. Clay Sci. 2013, 80-81:85-92.
62. Seema, Datta M. MMT-PLGA nanocomposites as an oral and controlled release carrier for 5-fluorouracil: a novel approach. Int. J. Pharm. Pharma. Sci. 2013, 5(2):332-341.
63. Seema, Datta M. Organoclay Pluronic F68-montmorillonite, as a sustained release drug delivery vehicle for propranolol hydrochloride. Eur. Chem. Bull. 2014, 3(6):593-604.
64. Shahi S.R., Tribhuwan S.D., Tadwee I.K., Gupta S.K., Zadbuke N.S., Shivanikar S.S. Formulation of atenolol mucoadhesive microspheres for nasal delivery by spray drying technique: in vitro/ex vivo evaluation. Der Pharm. Sin. 2011, 2(5):54-63.
65. Silva A.C.M., GaDlico D.A., Guerra R.B., Legendre A.O., Rinaldo D., Galhiane M.S., Bannach G. Study of some volatile compounds evolved from the thermal decomposition of atenolol. J. Therm. Anal. Calorim. 2013, 10.1007/s10973-013-3484-6.
66. Singh B., Chakkal S.K., Ahuja N. Formulation and optimization of controlled release mucoadhesive tablets of atenolol using response surface methodology. AAPS Pharm. Sci. Technol. 2006, 7(1):E1-E10.
67. Srivastava A.K., Wadhwa S., Ridhurkar D., Mishra B. Oral sustained delivery of atenolol from floating matrix tablets, formulation and in vitro evaluation 2005, 31(4-5):367-374.
68. Suresh R., Borkar S.N., Sawant V.A., Shende V.S., Dimble S.K. Nano clay drug delivery system. Int. J. Pharm. Sci. Nanotechnol. 2010, 3(2):901-905.
69. Thomas L.M., Khalil Y.I. Preparation and evaluation of atenolol floating beads as a controlled delivery system. Iraqi J. Pharm. Sci. 2011, 20(1):70-80.
70. Tombácz E., Szekeres M. Colloidal behavior of aqueous montmorillonite suspensions: the specific role of pH in the presence of indifferent electrolytes. Appl. Clay Sci. 2004, 27:75-94.
71. Vaithiyalingam S.R., Sastry S.V., Dehon R.H., Reddy I.K., Khan M.A. Long-term stability characterization of a controlled release gastro-intestinal therapeutic system coated with a cellulose acetate pseudolatex. Pharmazie 2001, 56:66-69.
72. Vázques M.J., Casalderrey M., Duro R. Atenolol release from hydrophilic matrix tablets with hydroxypropyl methylcellulose (HPMC) mixtures as gelling agent: effects of the viscosity of the HPMC mixture. Eur. J. Pharm. Sci. 1996, 4:39-48.
73. Viseras C., Aguzzzi C., Cerezo P., Bedmar M.C. Biopolymer clay nanocomposites for controlled drug delivery. Mater. Sci. Technol. 2008, 24:1020-1026.
74. Wander G.S., Chhabra S.T., Kaur K. Suppl. JAPI 2009, 57:13-16.
75. Wang X., Yumin D., Luo J. Biopolymer/montmorillonite nanocomposite: preparation drug-controlled release property and cytotoxicity. Nanotechnology 2008, 19:6570.
76. Yuan Q., Shah J., Hein S., Misra R.D.K. Controlled and extended drug release behavior of chitosan-based nanoparticle carrier. Acta Biomater. 2010, 6:1140-1148.
77. Zampori L., Stampino P.G., Cristiani C., Cazzola P., Dotelli G. Intercalation of poly(ethylene-oxides) in montmorillonite: tailor-made nanocontainers for drug delivery systems. Appl. Clay Sci. 2010, 50:266-270.
78. Zhang Z., Grijpma D.W., Feijen J. Poly(trimethylene carbonate) and monomethoxy poly(ethylene glycol)-block-poly(trimethylene carbonate) nanoparticles for the controlled release of dexamethasone. J. Control. Release 2006, 111:263-270.
79. Zhao L., Du J., Duan Y., Zang Y., Zhang H., Yang C., Cao F., Zhai G. Curcumin loaded mixed micelles composed of pluronic P123 and F68: preparation, optimization and in vitro characterization. Colloids Surf., B 2012, 97:101-108.